Technical Specifications

Page 10
/15
S
afety
D
ata
S
h
eet
according to 1907/2006/EC (REACH), 1272/2008/EC (CLP),
and
GHS
Printing date 17.07.
Revision:
17.07.2013
Trade name: Polycuramine PC 96 Part A
(Contd. of page 9)
11 Toxicological information
·
11.1 Information on toxicological effects
·
Acute toxicity:
·
L
D/
L
C50
v
al
u
es
r
ele
v
a
n
t
fo
r
classi
f
ica
t
i
on
:
1330
-
20
-
7
x
y
le
n
e
O
r
al
Dermal
LD50
LD50
4300
m
g/
k
g
(r
at)
2000 mg/kg (rabbit)
100
-
41
-
4
e
th
y
l
b
e
nz
e
n
e
O
r
al
Dermal
LD50
LD50
3500
m
g/
k
g
(r
at)
17800 mg/kg (rabbit)
106
-
89
-
8
1
-
c
h
l
o
r
o
-
2,3
-
e
po
x
y
p
r
op
a
n
e
O
r
al
Dermal
Inhalativ
e
LD50
LD50
LC50/4
h
90
m
g/
k
g
(r
at)
515 mg/kg (rabbit)
250 mg/l (rat)
·
Primary irritant effect:
·
on the skin: Irritant to skin and mucous membranes.
·
on the eye: Irritating effect.
· Sensitization:
Sensitizing effect through inhalation is possible by prolonged exposure.
Sensitization possible through skin contact.
· Additional toxicological information:
The product shows the following dangers according to the calculation m ethod of the General EU
Classification Guidelines for Preparations as issued in the latest version:
Irritant
Danger through skin adsorption.
Carcinogenic.
Toxic and/or corrosive effects may be delayed up to 24 hours.
·
Sensitisation: Sensitization possible by skin contact.
· Repeated dose toxicity:
May cause damage to organs through prolonged or repeated exposure .
Repeated exposures may result in skin and/or respiratory sensitivity.
· CMR effects (carcinogenity, mutagenicity and toxicity for reproduction):
Muta. 2
12 Ecological information
·
12.1 Toxicity
·
Aquatic toxicity: Toxic for aquatic organisms
·
12.2 Persistence and degradability The product is partially biodegradable. Significant residuals remain.
·
12.3 Bioaccumulative potential No further relevant information available.
·
12.4 Mobility in soil No further relevant information available.
(Contd. on page 11)
37.0.1